CRI CEO Dr. Jill O'Donnell-Tormey on How Data Drives Immunotherapy Advances
November 23, 2023
November 23, 2023
NEW YORK, Nov. 23 (TNSres) -- Cancer Research Institute issued the following news release:
Recently, the Cancer Research Institute's (CRI) CEO and Director of Scientific Affairs Jill O'Donnell-Tormey, PhD, sat down with Immuno-Oncology Insights to discuss the necessity for data-driven research as a catalyst for advances in cancer immunotherapy research. The interview covered a range of topics, from Dr. O'Donnell-Tormey's role at CRI to the organization's upcoming priorities.
< . . .
Recently, the Cancer Research Institute's (CRI) CEO and Director of Scientific Affairs Jill O'Donnell-Tormey, PhD, sat down with Immuno-Oncology Insights to discuss the necessity for data-driven research as a catalyst for advances in cancer immunotherapy research. The interview covered a range of topics, from Dr. O'Donnell-Tormey's role at CRI to the organization's upcoming priorities.
< . . .